COVID-19: Locked in a pro-inflammatory state
Macrophages absorbing cells infected with viable SARS-CoV-2 particles fail to transition into an anti-inflammatory state, potentially contributing to a damaging immune reaction linked to severe forms of COVID-19.
-
Download
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
COVID-19: Locked in a pro-inflammatory stateeLife 11:e80699.https://doi.org/10.7554/eLife.80699 - Cite
- CommentOpen annotations (there are currently 0 annotations on this page).
- School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong
In the last two and a half years, scientists all over the world have worked relentlessly to develop treatments and vaccines against SARS-CoV-2, the virus causing COVID-19. While considerable progress has been made identifying key properties of the virus, several fundamental questions remain. For example, it is still unclear why some people develop long COVID-19, or why others are asymptomatic.
Previous research has shown that some patients with COVID-19 can experience a cytokine storm, which is characterized by a high concentration of pro-inflammatory proteins called cytokines (Wong, 2021; Ragab et al., 2020). Cytokine storms can be an indicator of a poor disease prognosis, and research indicates that they contribute to long-term, and sometimes life-threatening, conditions in patients with long COVID-19 (Rai et al., 2021). Now, in eLife, Larissa Cunha and colleagues at the Universidade de São Paulo – including Ana Salina, Douglas dos-Santos, Tamara Rodrigues, and Marlon Fortes-Rocha as joint first authors – report new insights into how COVID-19 may cause cytokine storms (Salina et al., 2022).
Immune cells called macrophages are the major cell type responsible for cytokine storms in COVID-19 (Merad and Martin, 2020). Typically, they migrate to infected or damaged sites in the body, and upon contact with bacteria, viruses, or chemicals emitted by dying cells, produce proinflammatory cytokines (Figure 1). These, in turn, strengthen the response of other immune cells. Once the pathogens have been eliminated, macrophages stop producing proinflammatory cytokines and instead start releasing anti-inflammatory signals, which promote healing.
Figure 1
Phenotype change of macrophages in response to apoptotic cells.
An epithelial cell (shown in red) attacked by SARS-CoV-2 (white) activates immune cells, known as macrophages (yellow), via the cytokine interferon gamma (blue receptor). The macrophages then …
Previous research has shown that during this transition, macrophages change their phenotype from a proinflammatory state M1 to an anti-inflammatory one, M2 (Kohno et al., 2021). It was, however, unclear how they achieve this. To find out if the same transition happens after infection with COVID-19, Salina et al. used apoptotic lung and kidney cells (that is, cells undergoing regulated cell death) containing either viable SARS-CoV-2 particles, inactivated viral particles, or sterile culture medium. They then investigated if and how engulfing apoptotic cells, a process known as efferocytosis, affects the phenotypic change of the macrophages.
The results revealed that SARS-CoV-2 prevented M1 macrophages from changing into M2 macrophages, thereby increasing the inflammatory potential of these immune cells. In the experiments, only cells infected with viable SARS-CoV-2 blocked the M1 macrophages from changing into M2 macrophages and increased the amount of proinflammatory cytokines produced, such as IL-6. Experiments with another virus species did not achieve the same outcome, suggesting that the overproduction of IL-6 may be specific to SARS-CoV-2.
Salina et al. further tested the effect of antiviral drugs targeting the transcription process of viral RNA and found that viral RNAs appear to play a significant role in preventing macrophages changing into the anti-inflammatory state. Treating macrophages with the antiviral drug Remdesivir after they had engulfed cells with viable SARS-CoV-2 reduced the production of IL-6.
These observations indicate that viral RNAs – once taken up by macrophages – arrest the immune cells to remain in the M1 phenotype, which may contribute to the cytokine storm seen in patients with COVID-19. Moreover, absorbing cells containing viable SARS-CoV-2 reduced the number of proteins responsible for recognizing apoptotic cells. This led to a build-up of cell debris and apoptotic cells.
To find out how defective efferocytosis affects the pathogenesis of COVID-19, Salina et al. stained lung tissue samples from COVID-19 patients with immunofluorescent dyes and assessed the expression of efferocytosis receptor proteins. This revealed that lung samples had a lower level of gene expression linked to efferocytosis, which lead to a reduced clearance of cell debris. It also showed that the production of cytokines was dysfunctional, suggesting that SARS-CoV-2 over-activates macrophages in the lungs. This in turn, led to severe inflammation and impaired tissue regeneration. Furthermore, the residual cell debris induced signaling molecules that activated a type of immune cells, called monocytes, to become M1 macrophages. Combined, these changes could increase inflammation even further and may prolong a dysfunctional immune response long after recovery, potentially leading to long COVID-19 syndromes.
While many questions around COVID-19 and its long-term effects warrant further research, the study of Salina et al. provides valuable insights into the complex mechanisms of cytokine storms and may open new avenues for developing treatment plans for patients with severe COVID-19 (Misra et al., 2021; Gracia-Ramos et al., 2021; Ma et al., 2022; Batlle et al., 2022; Yeung et al., 2021).
References
-
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophagesNature Reviews Immunology 20:355–362.https://doi.org/10.1038/s41577-020-0331-4
-
The COVID-19 Cytokine Storm; What We Know So FarFrontiers in Immunology 11:1446.https://doi.org/10.3389/fimmu.2020.01446
-
Post covid 19 pulmonary fibrosis is it real threat?The Indian Journal of Tuberculosis 68:330.https://doi.org/10.1016/j.ijtb.2020.11.003
-
Inflammation in COVID-19: from pathogenesis to treatmentInternational Journal of Clinical and Experimental Pathology 14:831–844.
Article and author information
Author details
Publication history
Copyright
© 2022, Wang Chau and Sugimura
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 267
- downloads
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Further reading
-
- Immunology and Inflammation
Gastrointestinal (GI) colonization by methicillin-resistant Staphylococcus aureus (MRSA) is associated with a high risk of transmission and invasive disease in vulnerable populations. The immune and microbial factors that permit GI colonization remain unknown. Male sex is correlated with enhanced Staphylococcus aureus nasal carriage, skin and soft tissue infections, and bacterial sepsis. Here, we established a mouse model of sexual dimorphism during GI colonization by MRSA. Our results show that in contrast to male mice that were susceptible to persistent colonization, female mice rapidly cleared MRSA from the GI tract following oral inoculation in a manner dependent on the gut microbiota. This colonization resistance displayed by female mice was mediated by an increase in IL-17A+ CD4+ T cells (Th17) and dependent on neutrophils. Ovariectomy of female mice increased MRSA burden, but gonadal female mice that have the Y chromosome retained enhanced Th17 responses and colonization resistance. Our study reveals a novel intersection between sex and gut microbiota underlying colonization resistance against a major widespread pathogen.
-
- Biochemistry and Chemical Biology
- Immunology and Inflammation
During parasitoid wasp infection, activated immune cells of Drosophila melanogaster larvae release adenosine to conserve nutrients for immune response. S-adenosylmethionine (SAM) is a methyl group donor for most methylations in the cell and is synthesized from methionine and ATP. After methylation, SAM is converted to S-adenosylhomocysteine, which is further metabolized to adenosine and homocysteine. Here, we show that the SAM transmethylation pathway is up-regulated during immune cell activation and that the adenosine produced by this pathway in immune cells acts as a systemic signal to delay Drosophila larval development and ensure sufficient nutrient supply to the immune system. We further show that the up-regulation of the SAM transmethylation pathway and the efficiency of the immune response also depend on the recycling of adenosine back to ATP by adenosine kinase and adenylate kinase. We therefore hypothesize that adenosine may act as a sensitive sensor of the balance between cell activity, represented by the sum of methylation events in the cell, and nutrient supply. If the supply of nutrients is insufficient for a given activity, adenosine may not be effectively recycled back into ATP and may be pushed out of the cell to serve as a signal to demand more nutrients.
